In the 1900s, Élie Metchnikoff — the Russian biologist and 1908 Nobel laureate in Medicine — proposed a bold hypothesis: the exceptional longevity of Bulgarian peasants was linked to their daily consumption of fermented yogurt. That intuition anticipated, by a century, the scientific revolution we are living through today.
Gut microbiome research is one of the most active biological disciplines of the decade. And among its most promising fields of investigation: the link between microbiota composition and human longevity.
The microbiome: an invisible organ with essential functions
The gut microbiome refers to the entire community of microorganisms — bacteria, archaea, fungi, viruses and protists — colonising the human digestive tract. Their numbers are estimated at between 38 and 100 trillion, for a total mass of roughly 1-2 kilograms. Their collective genome — the metagenome — contains roughly 150 times more genes than the human genome.
This genomic density gives the microbiome metabolic capabilities the host organism doesn't have on its own: fermenting dietary fibre into short-chain fatty acids, synthesising certain vitamins (K2, B12, folate), regulating the gut immune system, and maintaining epithelial barrier integrity. The microbiome isn't a passenger in the body. It is a co-evolutionary partner whose functions have been integrated into human physiology for millions of years.
How the microbiome changes with age
In a healthy young adult, the microbiome is dominated by two major bacterial phyla: Firmicutes and Bacteroidetes. Diversity is high and composition relatively stable. With age, several changes have been documented across multiple cohorts: bacterial diversity declines — one of the most robust markers of microbiome aging. A study by Claesson et al. (Nature, 2012) of 178 elderly Irish people found that microbiome composition was strongly correlated with overall health status.
The proportion of pro-inflammatory bacteria rises at the expense of short-chain-fatty-acid producers such as Faecalibacterium prausnitzii and Roseburia intestinalis. Gut permeability increases — the so-called "leaky gut" phenomenon — allowing the systemic passage of bacterial fragments (LPS) that chronically activate innate immunity and contribute to inflammaging.
Centenarians: what does their microbiome say?
Biagi et al. (Current Biology, 2016) compared the microbiome of Italian centenarians, semi-supercentenarians (105+), older adults and young adults. Centenarians show a distinct microbiome composition — characterised by a greater abundance of beneficial bacteria and preserved diversity despite advanced age. Studies of centenarians in Sardinia, China and Japan have found converging signatures, suggesting that certain "longevity-associated" microbiome features transcend geographic differences.
Akkermansia muciniphila: the longevity bacterium
Among the bacteria whose relationship with longevity is best documented, Akkermansia muciniphila holds a special place. It colonises the mucous layer of the intestinal epithelium, contributing to the maintenance of gut barrier integrity. Several studies have shown an inverse correlation between its abundance and metabolic syndrome, obesity, type 2 diabetes and chronic systemic inflammation.
Wilmanski et al. (Nature Metabolism, 2021), studying 9,000 individuals, found that people over 80 in good functional health had a statistically distinct microbiome — with preserved diversity and specific metabolic profiles.
Metchnikoff had an intuition. Contemporary geroscience has turned it into a science.
The gut-brain axis: the microbiome and cognitive aging
The gut-brain axis is the set of bidirectional communication pathways between the gut microbiome and the central nervous system — via the vagus nerve, circulating metabolites and the immune system. Studies in mice have shown that transferring the microbiome from old mice to young mice accelerates certain markers of brain aging, and conversely, that transferring the microbiome from young mice to old mice improves certain cognitive performances.
Short-chain fatty acids (SCFAs) — butyrate, propionate, acetate — produced by bacterial fermentation of fibre, cross the blood-brain barrier and exert documented neuroprotective effects.
Dysbiosis, gut permeability and inflammaging
The causal sequence runs as follows: aging reduces microbiome diversity → butyrate-producing bacteria decline → gut permeability rises → bacterial fragments enter systemic circulation → they activate innate immunity's TLR4 receptors → inflammaging is fuelled. This mechanism places the microbiome at the intersection of several Hallmarks of Aging: dysbiosis, chronic inflammation, and altered intercellular communication.
Urolithin A: when the microbiome manufactures longevity actives
Urolithin A is a metabolite produced by the gut's biotransformation of ellagitannins — polyphenols found in pomegranates, walnuts and certain berries. This biotransformation is carried out by specific microbiome bacteria. Clinical studies published in Nature Metabolism and Cell Reports Medicine have shown that urolithin A activates mitophagy and improves muscle function in older adults.
What urolithin A illustrates is fundamental: the ability to produce certain bioactive metabolites isn't universal. It depends on the presence of specific bacteria — and roughly 30-40% of the population wouldn't produce significant urolithin A even with adequate precursor intake.
In conclusion
The gut microbiome is a functional organ whose composition governs mechanisms directly involved in longevity: gut barrier integrity, bioactive metabolite production, immune regulation, protection against inflammaging, and communication with the central nervous system.
Its inclusion as a full-fledged Hallmark of Aging in López-Otín's 2023 revision is the scientific recognition of a decade of transformative research — and one of the reasons we included microbiome-supporting actives in the Cellular Daily composition.
This article is published for informational and educational purposes. It does not constitute medical advice and does not replace consultation with a healthcare professional.
